• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 20 Results
Document Number CR220440
 
 1 
 2 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas c 303  {Lithium} 
CR220440 k063684 Lithium Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {Mycophenolic Acid} 
CR220440 k063520 Mycophenolic acid Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ONLINE DAT Amphetamines II} 
CR220440 k083764 Amphetamines Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ONLINE DAT Barbiturates Plus} 
CR220440 k043211 Barbiturates Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ONLINE DAT Cannabinoids II} 
CR220440 k030213 Cannabinoids (THC) Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ONLINE DAT Cocaine II} 
CR220440 k023281 Cocaine metabolites Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ONLINE DAT Lysergic Acid Diethylamide} 
CR220440 k972250 Lysergic acid diethylamide (LSD) Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ONLINE DAT Methaqualone} 
CR220440 k945187 Methaqualone Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ONLINE DAT Phencyclidine Plus} 
CR220440 k043305 Phencyclidine (PCP) Toxicology / TDM MODERATE 12/05/2022
Roche Diagnostics, cobas c 303  {ONLINE TDM Amikacin} 
CR220440 k032279 Amikacin Toxicology / TDM MODERATE 12/05/2022

-
-